Author

Jesus Aparicio 1

1 Takeda, Madrid, Spain

LINKING LOCATION SPECIFIC GENE EXPRESSION PATTERNS TO POTENTIAL VEDOLIZUMAB OUTCOMES IN CROHN’S DISEASE PATIENTS

Bernat Regí, Ignacio Tagarro, Arnau Lagarda, TERESA LETOSA, Jesus Aparicio, Mireia Coma, Carmen Montoto Otero, Josep Manye, Eugeni Domenech Morral

OBSERVATIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN AN ULCERATIVE COLITIS POPULATION COMPRISED BY BIO-NAÏVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Francisco Casellas, Cristina Rodriguez, Claudia Herrera de Guise, Javier Pérez Gisbert, Isabel Vera Mendoza, María Dolores Martín-Arranz, Sabino Riestra, Pilar Martínez-Montiel, Vanesa Royo, Patricia Suárez, Esther García-Planella, Orlando Garcia-Bosch, Marisa Iborra, Ana Gutierrez Casbas, Jesus Aparicio, Alonso Fernandez-Ni

REAL WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN CROHN’S DISEASE WHEN USED AS A FIRST BIOLOGIC OR AFTER FAILURE OF ONE PREVIOUS ANTI-TNF (EVOLVE-IB STUDY)

Fernando Muñoz, Cristina Rodriguez, Javier Pérez Gisbert, Claudia Herrera de Guise, Isabel Vera Mendoza, Ana Gutierrez Casbas, María Dolores Martín-Arranz, Pilar Martínez-Montiel, Vanesa Royo, Patricia Suárez, Esther García-Planella, Orlando Garcia-Bosch, Marisa Iborra, Jesus Aparicio, Ignacio Tagarro, Alonso Fernandez-Nista

UNDERSTANDING THE IMPACT OF PREVIOUS TNF-ALPHA INHIBITORS ON VEDOLIZUMAB RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE USING SYSTEMATIC REVIEW AND GENE EXPRESSION DATA

Bernat Regí, Ignacio Tagarro, Arnau Lagarda, TERESA LETOSA, Jesus Aparicio, Mireia Coma, Carmen Montoto Otero, Josep Manye, Eugeni Domenech Morral

Item 1 - 4 / 4
1